FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ATELVIA (risedronate sodium) from Allergan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• ATELVIA (RISENDRONATE SODIUM)

Snippet

SUPPL AP for ATELVIA (RISEDRONATE SODIUM)